We are live on ! Find out more
CVS icon

CVS Health

1,211 hedge funds and large institutions have $71.4B invested in CVS Health in 2013 Q4 according to their latest regulatory filings, with 157 funds opening new positions, 425 increasing their positions, 492 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more first-time investments, than exits

New positions opened: 157 | Existing positions closed: 65

65% more funds holding in top 10

Funds holding in top 10: 83137 (+54)

22% more capital invested

Capital invested by funds: $58.3B → $71.4B (+$13.1B)

7% more funds holding

Funds holding: 1,1301,211 (+81)

9% more call options, than puts

Call options by funds: $355M | Put options by funds: $326M

0.98% more ownership

Funds ownership: 82.97%83.95% (+0.98%)

14% less repeat investments, than reductions

Existing positions increased: 425 | Existing positions reduced: 492

Holders
1,211
Holders Change
+81
Holders Change %
+7.17%
% of All Funds
35.14%
Holding in Top 10
137
Holding in Top 10 Change
+54
Holding in Top 10 Change %
+65.06%
% of All Funds
3.98%
New
157
Increased
425
Reduced
492
Closed
65
Calls
$355M
Puts
$326M
Net Calls
+$29.3M
Net Calls Change
+$78.1M
Name Holding Trade Value Shares
Change
Change in
Stake
WFM
651
Wilmington Funds Management
Delaware
$2.79M -$1.86M -28,881 -43%
PBT
652
Pictet Bank & Trust
Bahamas
$2.76M +$2.48M +38,615 New
Mackenzie Financial
653
Mackenzie Financial
Ontario, Canada
$2.75M -$69.3M -1,079,014 -97%
BT
654
Bankers Trust
Iowa
$2.73M +$61.4K +956 +3%
CNBT
655
Canandaigua National Bank & Trust
New York
$2.67M +$8.54K +133 +0.4%
PCMI
656
Paradigm Capital Management Inc
New York
$2.66M -$261K -4,065 -10%
SHA
657
Smith Hayes Advisers
Nebraska
$2.59M +$22.4K +348 +1%
MIM
658
Merit Investment Management
Delaware
$2.58M -$955K -14,859 -29%
ACP
659
Aviance Capital Partners
Florida
$2.57M +$93.2K +1,450 +4%
DC
660
Davenport & Co
Virginia
$2.57M +$10.2K +158 +0.4%
CA
661
Cullinan Associates
Kentucky
$2.57M -$161K -2,500 -7%
DCM
662
Delta Capital Management
New Jersey
$2.56M -$16.1K -250 -0.7%
RBA
663
Richard Bernstein Advisors
New York
$2.56M +$219K +3,413 +11%
SCM
664
Silver Capital Management
New York
$2.55M
KCM
665
Kames Capital Management
United Kingdom
$2.55M
FFSOTS
666
Fiduciary Financial Services of The Southwest
Texas
$2.53M +$308K +4,800 +16%
CCM
667
Catapult Capital Management
New York
$2.53M +$2.27M +35,301 New
CCM
668
Compton Capital Management
Rhode Island
$2.52M -$12.8K -200 -0.6%
HPC
669
HM Payson & Co
Maine
$2.51M -$3.15K -49 -0.1%
RIL
670
Rothschild Investment LLC
Illinois
$2.49M -$25.7K -400 -1%
RJFSA
671
Raymond James Financial Services Advisors
Florida
$2.48M -$104K -1,612 -4%
WI
672
WHV Investments
California
$2.44M -$5.18M -80,682 -70%
KCM
673
Kanawha Capital Management
Virginia
$2.41M +$6.42K +100 +0.3%
PWM
674
Perigon Wealth Management
California
$2.4M +$2.16M +33,600 New
Cambridge Investment Research Advisors
675
Cambridge Investment Research Advisors
Iowa
$2.38M +$82K +1,276 +4%

CVS Hedge Fund Activity: Q4 2013 in Review

1,211 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2013, worth a combined $71.4B — up 22% from $58.3B a quarter earlier.

Buyers outnumbered sellers: 157 funds opened new CVS positions and 65 closed out — a net gain of 92 holders — while 425 added to existing stakes and 492 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $207M. The largest seller was Fidelity Investments, cutting an estimated $557M.

  • 1,211 institutional investors held CVS Health (CVS) as of Q4 2013, up from 1,130 in Q3 2013.
  • Funds reported $71.4B of CVS Health stock for Q4 2013, up 22% quarter-over-quarter.
  • 157 funds opened new CVS Health positions in Q4 2013 and 65 closed out, a net change of +92 holders.
  • The largest CVS Health buyer in Q4 2013 was AllianceBernstein, an estimated $207M added.
  • The largest CVS Health seller in Q4 2013 was Fidelity Investments, an estimated $557M sold.

Based on aggregated 13F filings for Q4 2013.